Schering-Plough Europe has withdrawn its European marketing authorisation application for the proposed asthma treatment, Zenhale (mometasone furoate/formoterol fumarate), the European Medicines Agency announced. ---Subscribe to MedNous to access this article--- Regulation & Policy Company News
